{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T05:19:44Z","timestamp":1726463984450},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.canep.2016.10.018","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T17:31:08Z","timestamp":1478885468000},"page":"177","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["There is no point in cervical cancer screening below 25 years of age"],"prefix":"10.1016","volume":"45","author":[{"given":"Wiebren A.A.","family":"Tjalma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2016.10.018_bib0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canep.2015.12.011","article-title":"Surveillance of effects of HPV vaccination in Belgium","volume":"41","author":"Arbyn","year":"2016","journal-title":"Cancer Epidemiol."},{"issue":"3","key":"10.1016\/j.canep.2016.10.018_bib0010","first-page":"211","article-title":"The ideal cervical cancer screening recommendation for Belgium, an industrialized country in Europe","volume":"35","author":"Tjalma","year":"2014","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"February (3)","key":"10.1016\/j.canep.2016.10.018_bib0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.canep.2016.10.018_bib0020","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1200\/JCO.2014.59.0331","article-title":"There are two prophylactic human papillomavirus vaccines against cancer, and they are different","volume":"33","author":"Tjalma","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canep.2016.10.018_bib0025","doi-asserted-by":"crossref","first-page":"e92615","DOI":"10.1371\/journal.pone.0092615","article-title":"Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002\u20132006)","volume":"9","author":"Arbyn","year":"2014","journal-title":"PLoS One"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782116302089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782116302089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T15:54:21Z","timestamp":1536249261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782116302089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":5,"alternative-id":["S1877782116302089"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2016.10.018","relation":{},"ISSN":["1877-7821"],"issn-type":[{"type":"print","value":"1877-7821"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"There is no point in cervical cancer screening below 25 years of age","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2016.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}